Glenmark receives final ANDA approval for Norethindrone Acetate and Ethinyl Estradiol tablets

Glenmark Generics Inc. USA, a subsidiary of Glenmark Generic has been granted final ANDA from the USFDA for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5mcg and 1 mg/5 mcg. Glenmark will commence distribution of the product immediately.

April 07, 2015 / 09:42 IST

live

bselive
nselive

Volume

Todays L/H

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated April 07, 2015, titled "Glenmark receives final ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5 mcg and 1mg/5 mcg.".Source : BSE

Read all announcements in Glenmark

first published: Apr 7, 2015 09:42 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347